4//SEC Filing
Zinda Michael 4
Accession 0001209191-23-035135
CIK 0001808158other
Filed
Jun 6, 8:00 PM ET
Accepted
Jun 7, 4:55 PM ET
Size
5.3 KB
Accession
0001209191-23-035135
Insider Transaction Report
Form 4
Zinda Michael
EVP, CHIEF SCIENTIFIC OFFICER
Transactions
- Sale
Common Shares
2023-06-06$12.04/sh−1,200$14,448→ 69,391 total
Footnotes (2)
- [F1]This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2022.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.00 to $12.08 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Repare Therapeutics Inc.
CIK 0001808158
Entity typeother
Related Parties
1- filerCIK 0001815366
Filing Metadata
- Form type
- 4
- Filed
- Jun 6, 8:00 PM ET
- Accepted
- Jun 7, 4:55 PM ET
- Size
- 5.3 KB